Lung blood tests may guide smarter treatment for pulmonary hypertension
NCT ID NCT01961232
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding special blood tests (biomarkers) to the usual heart-lung exam can help doctors pick the right therapy for people with pulmonary hypertension. About 100 adults undergoing a routine heart catheterization will have extra blood samples taken from their lungs. The goal is to see if these markers lead to better treatment choices and improved outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scoliosis's hidden toll: can we predict lung and heart risks?
- Which breathing setting keeps Kids' lungs healthier during heart surgery?
- Could a simple sleep guide ease insomnia in lung disease?
- A Needle-Free heart check? MRI may replace invasive catheterization
- Can a diabetes drug help the lungs? pioglitazone put to the test for pulmonary hypertension
- Zapping lung nerves could ease heart Failure-Related high blood pressure